| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains
|
Pawlowski, Andrzej
|
|
|
3 |
2 |
p.
|
article
|
| 2 |
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer
|
Johnson, Brett E.
|
|
|
3 |
2 |
p.
|
article
|
| 3 |
Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
|
Shapiro, Roman M.
|
|
|
3 |
2 |
p.
|
article
|
| 4 |
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
|
Nahi, Hareth
|
|
|
3 |
2 |
p.
|
article
|
| 5 |
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
|
Pradenas, Edwards
|
|
|
3 |
2 |
p.
|
article
|
| 6 |
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma
|
Freeman, Samuel S.
|
|
|
3 |
2 |
p.
|
article
|
| 7 |
Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2’s evasive maneuvering
|
Grunst, Michael W.
|
|
|
3 |
2 |
p.
|
article
|
| 8 |
Genetic resiliency associated with dominant lethal TPM1 mutation causing atrial septal defect with high heritability
|
Teekakirikul, Polakit
|
|
|
3 |
2 |
p.
|
article
|
| 9 |
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
|
Sulbaran, Guidenn
|
|
|
3 |
2 |
p.
|
article
|
| 10 |
Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children
|
Yegorov, Sergey
|
|
|
3 |
2 |
p.
|
article
|
| 11 |
Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain
|
Miller, Nathaniel L.
|
|
|
3 |
2 |
p.
|
article
|
| 12 |
Ligand-mediated PAI-1 inhibition in a mouse model of peritoneal carcinomatosis
|
Hendrikson, Josephine
|
|
|
3 |
2 |
p.
|
article
|
| 13 |
Medicine as constraint: Assessing the barriers to gender-affirming care
|
Kumar, Anish
|
|
|
3 |
2 |
p.
|
article
|
| 14 |
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
|
Edara, Venkata-Viswanadh
|
|
|
3 |
2 |
p.
|
article
|
| 15 |
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses
|
Ishii, Hiroshi
|
|
|
3 |
2 |
p.
|
article
|
| 16 |
Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children
|
Costa-Martins, André G.
|
|
|
3 |
2 |
p.
|
article
|
| 17 |
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity
|
Richardson, Simone I.
|
|
|
3 |
2 |
p.
|
article
|
| 18 |
Selective targeting of skin pathobionts and inflammation with topically applied lactobacilli
|
Lebeer, Sarah
|
|
|
3 |
2 |
p.
|
article
|
| 19 |
Starving lethal prostate cancer by targeting heat shock proteins and glycolytic enzymes
|
Plymate, Stephen R.
|
|
|
3 |
2 |
p.
|
article
|
| 20 |
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer
|
Rice, Meghan A.
|
|
|
3 |
2 |
p.
|
article
|
| 21 |
System-wide transcriptome damage and tissue identity loss in COVID-19 patients
|
Park, Jiwoon
|
|
|
3 |
2 |
p.
|
article
|
| 22 |
Teach ‘em young: Influenza vaccines induce broadly neutralizing antibodies in children
|
Dugan, Haley L.
|
|
|
3 |
2 |
p.
|
article
|
| 23 |
The Human Tumor Atlas Network’s beginning steps toward the future of collaborative multi-omic discovery
|
Page, David B.
|
|
|
3 |
2 |
p.
|
article
|
| 24 |
Toward the development of a protein-based group B Streptococcus vaccine
|
Dominguez, Kristen
|
|
|
3 |
2 |
p.
|
article
|
| 25 |
Why rare disease needs precision medicine—and precision medicine needs rare disease
|
Might, Matthew
|
|
|
3 |
2 |
p.
|
article
|
Journal description